comparemela.com

Latest Breaking News On - Aadi bioscience - Page 5 : comparemela.com

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients.

United-states
San-francisco
California
American
Gopa-iyer
Nasdaq
American-society-of-clinical-oncology
Prnewswire-aadi-bioscience-inc
Linkedin
Twitter
Aadi-bioscience-inc
Foundation-medicine

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
San-francisco
California
American
Dustin-deming
Scott-paulson
Aadi-bioscience
Marcy-graham
Aadi-bioscience-inc
Nasdaq
Foundation-medicine
Prnewswire-aadi-bioscience-inc

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients.

San-francisco
California
United-states
American
Scott-paulson
Dustin-deming
Foundation-medicine
Nasdaq
Aadi-bioscience-inc
American-society-of-clinical-oncology
Prnewswire-aadi-bioscience-inc
Clinical-oncology

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 29.3% in December

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 29.3% in December
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Piper-sandler
Neil-desai
Aadi-bioscience
Royal-bank
Goldman-sachs-group-inc
Aadi-bioscience-inc
Renaissance-technologies
Nasdaq
Get-free-report
Chairman-neil-desai
Street-corp

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Increase in Short Interest

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 789,000 shares, a growth of 6.1% from the November 15th total of 743,700 shares. Currently, 4.6% of the company’s stock are sold short. Based on an […]

Canada
Neil-desai
Aadi-bioscience
Piper-sandler
Group-plc
Citigroup-inc
Securities-exchange-commission
Royal-bank
Aadi-bioscience-company-profile
Nasdaq
Barclays-plc
Aadi-bioscience-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.